For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab108529? Please let us know so that we can cite the reference in this datasheet.
ab108529 has been referenced in 4 publications.
- Lin A et al. CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials. Elife 6:N/A (2017).
- Wang Y et al. Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival. Proc Natl Acad Sci U S A 113:9810-5 (2016).
- Wang Y et al. MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife 3:e01763 (2014).
- Kig C et al. Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells. J Biol Chem 288:24200-12 (2013).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"